| Application no. and date | 18186075.0 (espacenet) (Federated) (European Patent Register), 20130729 | | Patent/reg. no. and date | DK/EP 3417862, 20210505 | | Publication date | 20181226 | | Priority no. and date | EP 12178187, 20120727, US 201261676348 P, 20120727 | | EP pub. no. and date |
EP 3417862 20181226 | | Effective date | | | Applicant/owner | Neurodyn Life Sciences Inc., Suite 508 NRC-INH
550 University Ave
Charlottetown C1A 4P3, CA | | Applicant ref. no. | N003-004/DK NR | | Inventor | Maelicke, Alfred, -
deceased, DE | | Representative | Gotapatent AB, Box 3127
S-550 03 Jönköping, SE | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/55 (2006.01) , A61K 9/00 (2006.01) , A61K 9/107 (2006.01) , A61K 9/14 (2006.01) , A61P 25/28 (2006.01) | | Title | FORBEDRET HJERNE BIOTILGÆNGELIGHED AF GALANTAMIN VED UDVALGTE FORMULERINGER OG TRANSMUCOSAL ADMINISTRATION AF LIPOFILE PRODRUGS | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
